comparemela.com

Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance

Card image cap

Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance

itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Albert Bourla , Cost Realignment Program , European Union , Pfizer Inc , Administration Site Conditions , Us Strategic National Stockpile , Strategic National , Pfizer , Drug Administration , Significant Uncertainty , Providing Pathway , Amended Supply Agreement , Non Cash Transaction , Return Estimated , Labeled Paxlovid Treatment Courses , Receive Credit , Treatment Courses , Patient Assistance Program , Provide Paxlovid Free , Federally Insured Patients , Underinsured Patients , Recognize Revenue , Commercialize Paxlovid , Privately Insured Commercial Patients , Paxlovid Revenues , Non Cash Revenue Reversal , Comirnaty Revenues , Non Cash Charge , Quarter Primarily , Operational Revenue Growth Expectations , Enterprise Wide Cost Realignment Program Expected , Deliver Targeted Savings , Lower Expected Revenues , Inventory Write Offs , Partially Offset , Amended Agreement , Emergency Use Authorized , National Stockpile , Goods Sold , Effective Tax Rate , Press Release Footnote , Chief Executive Officer , Adjusted Income , Financial Condition , Emergency Use Authorization , Serious Adverse Reactions Due , Drug Interactions , Immune System Disorders , Subcutaneous Tissue Disorders , System Disorders ,

comparemela.com © 2020. All Rights Reserved.